NDC 36987-2623
Bald Cypress
Bald Cypress
Bald Cypress is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Taxodium Distichum Pollen.
| Product ID | 36987-2623_90c4b6c4-a7f2-4ba8-927c-8440e0df96f5 |
| NDC | 36987-2623 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bald Cypress |
| Generic Name | Bald Cypress |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | TAXODIUM DISTICHUM POLLEN |
| Active Ingredient Strength | 20000 [PNU]/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2623-4
50 mL in 1 VIAL, MULTI-DOSE (36987-2623-4)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2623-1 [36987262301]
Bald Cypress INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2623-4 [36987262304]
Bald Cypress INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2623-3 [36987262303]
Bald Cypress INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2623-2 [36987262302]
Bald Cypress INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TAXODIUM DISTICHUM POLLEN | 20000 [PNU]/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Bald Cypress" or generic name "Bald Cypress"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2621 | Bald Cypress | Bald Cypress |
| 36987-2622 | Bald Cypress | Bald Cypress |
| 36987-2623 | Bald Cypress | Bald Cypress |
| 36987-2624 | Bald Cypress | Bald Cypress |
| 36987-2625 | Bald Cypress | Bald Cypress |
| 36987-2626 | Bald Cypress | Bald Cypress |
| 36987-2627 | Bald Cypress | Bald Cypress |
| 36987-2628 | Bald Cypress | Bald Cypress |
| 49288-0144 | Bald Cypress | Bald Cypress |
| 0268-6620 | TAXODIUM DISTICHUM POLLEN | Bald Cypress |
Trademark Results [Bald Cypress]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BALD CYPRESS 87742106 not registered Live/Pending |
Scott DeRouen 2018-01-03 |
BALD CYPRESS 87742106 not registered Live/Pending |
Debora DeRouen 2018-01-03 |
 BALD CYPRESS 87183065 5347516 Live/Registered |
Bell, Andrew P. 2016-09-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.